title: Fractionated radiosurgery for 9L gliosarcoma in the rat brain.
abstract: OBJECTIVE
  Fractionated radiosurgery is being carried out in the clinic to improve the therapeutic ratio of single-dose radiosurgery using various fractionation schemes. Because there is a paucity of experimental radiobiological data in the literature on the tumor response and late-responding normal tissue of critical intracranial structures to radiosurgery, the present animal study was designed to compare the response following a single high dose of radiation with that obtained from calculated fractionated doses of radiosurgery.
  
  
  METHODS
  Male Fischer rats with 9L gliosarcoma growing in their brains were stereotactically irradiated and assayed for the tumor control rate and brain tissue damage. The radiation dose needed for 50% tumor control (TCD50) was used as the endpoint of the efficacy of radiosurgery. Normal brain damage was measured histologically following a period of time over 270 days. Histological evaluation included hematoxylin-eosin (H & E), Luxol fast blue and periodic acid Schiff (LFB/PAS) for the presence of myelin and glial fibrillary acidic protein (GFAP) for the assessment of astrocytic re-activity. The optical density of optic nerves and chiasms staining with LFB/PAS was quantitatively measured using a computer image analysis to assess the magnitude of demyelination.
  
  
  RESULTS
  Radiosurgery (RS) was found to be more effective in curing small tumors than large tumors. The dose required to control 50% of the tumored animals for 120 days was 24, 31, and 40 Gy for 2-, 6-, and 12-day-old tumors, respectively. Using 12-day-old brain tumors, two fractions of 23.5 Gy and three fractions of 18.5 Gy were found to be equivalent to the single dose of 35 Gy for tumor control. For normal brain damages, the visual pathways including optic nerves and chiasm were found to be highly radiosensitive structures. A single dose of 35 Gy produced 100% severe optic neuropathy. The fractionated RS regimens spared substantial optic nerve damage.
  
  
  CONCLUSIONS
  The present data provide a strong radiobiological rationale for the use of fractionated RS in the treatment of tumors located near critical normal structures, including visual pathways. The sparing effect of fractionated RS is greater for late-responding tissues, relative to the rapidly proliferating tumor tissues. This report also characterizes the dose/time tolerance relationship of optic neuropathy after single and fractionated RS.
authors.affiliation: Department of Radiation Oncology, Henry Ford Hospital, Detroit, MI 48202, USA.
authors.forename: J H
authors.initials: JH
authors.lastname: Kim
authors.forename: M S
authors.initials: MS
authors.lastname: Khil
authors.forename: A
authors.initials: A
authors.lastname: Kolozsvary
authors.forename: J A
authors.initials: JA
authors.lastname: Gutierrez
authors.forename: S L
authors.initials: SL
authors.lastname: Brown
mesh_terms: D000818:Animals; D001932:Brain Neoplasms / Q000473:pathology / Q000601:surgery*; D019583:Dose Fractionation, Radiation; D004307:Dose-Response Relationship, Radiation; D018316:Gliosarcoma / Q000473:pathology / Q000601:surgery*; D008297:Male; D009901:Optic Nerve Diseases / Q000209:etiology; D011833:Radiation Injuries, Experimental / Q000209:etiology; D011853:Radiobiology; D016634:Radiosurgery; D051381:Rats; D011916:Rats, Inbred F344; D014407:Tumor Cells, Cultured